The substance quickly penetrates the cornea and reaches the aqueous humour. It is reduced to dihydrolevobunolol, which is equally active, in the eye's tissues.
This substance quickly enters the cornea and reaches the aqueous humor.  It is then transformed into dihydrolevobunolol, a compound with similar effectiveness within the eye's tissues.